Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions Nvidia Reports Another Blowout Quarter Revenue Surges 85 to 816 Billion in Fiscal Q1 AnheuserBusch InBev Shares Dip After Sales Miss Estimates Veteran Trader Steve Burns Warns of Overlooked Bear Market Signal and Deadly StockMarket Sins FTSE Index Rejig Adds Tata Capital Lenskart and Groww Among Six Stocks to Global Indices DHT Holdings Q1 2026 Earnings Strong EPS Beat Amid Tanker Market Strength MLYS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Ahead of Key Trial Data ET Q1 2026 Earnings Earnings Miss Expectations as Margin Pressures Persist VVOS Q4 2025 Earnings EPS Misses Estimates as Loss Widens Stock Gains 431 Clorox CLX Q1 2026 Earnings EPS Surprises to the High Side Amid Muted Revenue Outlook MBAI Q3 2023 Earnings WiderThanExpected Loss Weighs on Shares American Financial Group AFG Declines 158 as Stock Hovers Near Support Zone Easterly Government Properties DEA Gains 131 as Support Holds Whats Next for the GovernmentLeased REIT Western Copper and Gold WRN Holds Near Support Amid Modest Decline Estrella Immunopharma ESLA Gains 265 as Shares Find NearTerm Support at 11 Jefferies Financial Group JEF Holds Steady Near 5256 as Support and Resistance Define Trading Range FirstSun Capital Bancorp Q1 2026 Earnings EPS Misses Estimates Stock Slips Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction ZION Q1 2026 Earnings EPS Surpasses Estimates by Over 7 Amid Solid Operating Performance LEN Q1 2026 Earnings Lennar Misses EPS Estimates Despite Marginal Stock Gains Cadiz Inc Depositary Shares CDZIP Q1 2026 Earnings Narrower Loss Than Expected Amid Water Operations ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Lower Core Inflation Accelerates to 32 in March as Q1 GDP Growth Slows to 2 Oil Spike from Iran Conflict Poses Fed Policy Challenge BMO Q1 2026 Earnings Strong EPS Beat Drives Optimism Amid Steady Performance Medicus Pharma Ltd MDCX Climbs 66 Amid Renewed Interest Resistance at 032 in Focus